Cresco Labs Q2 revenue up 5.9% on Pennsylvania dispensary deals, Ohio adult-use

Multi-state operator reports quarterly growth driven by Pennsylvania acquisitions and Ohio recreational entry.

FILE — harvest · My 420 Tours / CC BY-SA 4.0

Cresco Labs reported Q2 2026 revenue growth of 5.9%, citing Pennsylvania dispensary acquisitions and entry into Ohio's adult-use market as key drivers. The results arrive as Pennsylvania's medical cannabis market continues to consolidate—Green Thumb opened a RISE location in Hanover in late July, while Vireo Growth closed a dispensary license acquisition earlier that month. Pennsylvania currently maintains 181 open retail locations.

The timing reflects broader M&A activity in the state even as legalization remains stalled in the legislature. Pennsylvania lawmakers rejected a marijuana oversight proposal in June, and while Democratic lawmakers held testimony on legalization and clean slate laws in April, no adult-use bill has advanced. The state's medical-only framework continues to generate growth for established operators willing to acquire existing licenses.

Cresco's expansion into Ohio's newly launched adult-use market signals operator confidence in the Midwest corridor. Watch whether Pennsylvania's persistent regulatory inertia accelerates M&A consolidation among existing license holders, or whether federal policy shifts prompt faster state-level movement on legalization.